Pathogenesis of idiopathic myelofibrosis: role of growth factors.
Open Access
- 1 June 1992
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 45 (6) , 461-464
- https://doi.org/10.1136/jcp.45.6.461
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- PROPOSED CLASSIFICATION FOR THE MYELODYSPLASIA/MYELOFIBROSIS SYNDROMESBritish Journal of Haematology, 1991
- Autocrine and/or paracrine mechanism operate during the growth of human bone marrow fibroblastsBritish Journal of Haematology, 1991
- REDUCED PLATELET PDGF LEVELS IN IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1991
- Platelet-Derived Mitogenic Activity and Bone Marrow Fibrosis in Myeloproliferative DisordersPathophysiology of Haemostasis and Thrombosis, 1990
- Serum procollagen‐III‐peptide level correlates with disease activity in myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 1989
- Platelet‐derived growth factor is decreased in patients with myeloproliferative disordersAmerican Journal of Hematology, 1988
- Serum markers for type IV collagen and type III procollagen in the myelofibrosis‐osteomyelosclerosis syndrome and other chronic myeloproliferative disordersAmerican Journal of Hematology, 1986
- Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosisScandinavian Journal of Clinical and Laboratory Investigation, 1986
- Immuno‐enzymatic detection of fibronectin in normal and pathological haematopoietic tissueBritish Journal of Haematology, 1985
- Biochemical and Histological Analysis of Bone Marrow Collagen in MyelofibrosisBritish Journal of Haematology, 1979